Roger Odd

Chairman of the Board

After qualifying as a Pharmacist Roger worked for Boots the chemists. He was elected to the Council of the then Pharmaceutical Society for three years from 1977 to 1980. He was then recruited by the Society as head-designate of the practice division in 1990, and took over as head in 1991 on the retirement of Bruce Rhodes.

When the Society restructured in 1998 Roger moved to the new Public Affairs Directorate as head of professional and scientific support. In this capacity he contributed to the Society’s work in a number of areas, including management of the British Pharmaceutical Conference and support for the science secretariat. In addition, he was involved with many aspects of membership activity, including looking after the branch network. He was also involved in running the Agricultural and Veterinary Pharmacy Group and represented the RSGB at European level. Roger was also the Society’s spokesman and was often interviewed on radio and TV.

Roger was a key promoter of the reclassification of Levonorgestrel to “P” status in the UK following an episode while practising in community pharmacy. He was legally unable to sell the EHC to a very distressed patient who then tried to commit suicide. This motivated him to lobby for a change of status, which was achieved when Levonelle became a “P” product in 2001.

During his time at the RPSGB Roger became interested in the work of CPA. It was on his retirement he became much more actively involved having been appointed to the post of Hon. Treasurer and in 2009 the post of Hon Secretary. He was one of the first Trustees when the CPA achieved charitable status in 2015, and in 2017 he was awarded CPA Fellowship as well as the Albert Howell award for outstanding contribution to the Association.

Tim Hanlon

Honorary Treasurer

Dr Tim Hanlon was appointed as a Trustee of the Commonwealth Pharmacists’ Association in 2017 and then as Honorary Treasurer in 2019.

He has held Chief Pharmacist posts in Primary and Community Care, Mental Health and Acute Hospital Care and has worked in Germany, Australia and New Zealand as well as the UK. His most recent appointment was as Chief Pharmacist and Clinical Director of Pharmacy and Medicines Optimisation at the academic healthcare organisation Guy’s and St Thomas’ Hospitals in London.

Tim holds Visiting Professor appointments at both the School of Cancer and Pharmaceutical Sciences of King’s College London, UK and the School of Pharmacy of the University of Reading, UK as well as an Adjunct Research Fellow post at the Victoria University of Wellington, New Zealand.

Rao V. S. V. Vadlamudi

President and Regional Representative for Asia

Dr. Rao Vadlamudi, in a career spanning over three and half decades, has
the unique distinction of associated with both academics and the
pharmaceutical industry. Dr. Vadlamudi held teaching assignments at the
Institute of Chemical Technology – erstwhile UDCT, and the Bombay
College of Pharmacy, Mumbai, where he served as the
first ever Director of the institute during 2004-07. He also held positions
of the Director, St. Peter’s Institute of Pharmaceutical Sciences,
Hanamkonda, Telangana, India and an adjunct professor, at the Acharya
BM Reddy College of Pharmacy in Bengaluru, India. He, for over two
decades, was associated with cutting–edge drug discovery and
development programs in both multinational and Indian pharma
companies, including Hoechst, Nicholas Piramal, Suven Life Sciences and
Nektar Therapeutics. He also served as the editor of the Indian Journal of
Pharmaceutical sciences for over two decades from 1994-
2014 and was the president of the Indian Pharmaceutical Association for
the term 2014-2018. He is currently the professional secretary of the
SEARPharm Forum, which is the FIP-WHO Forum of the South East Asian
countries national pharmaceutical associations. Rao Vadlamudi received
several awards of which the most significant one is the Eminent
Pharmacist Award of the IPA in 2013. Dr. Vadlamudi obtained a B. Pharm
and M. Pharm from Andhra University, Visakhapatnam, India and an M.
Sc. and a Ph.D. in pharmaceutical sciences from the University of British
Columbia, Vancouver BC, Canada. He has 25 publications and 13 patents
to his credit.

As the newly elected president of the Commonwealth Pharmacists
Association, Dr. Vadlamudi’s top priority would be to focus on the CPA’a
goal of ‘empowering pharmacists to improve health and wellbeing
throughout the Commonwealth’, working along with the CPA Secretariat,
Vice Presidents, Regional Representatives, and Councilors to build a
strong collaborative network across the commonwealth to exchange and
propagate best practices of pharmacy and pharmaceutical sciences. Dr.
Vadlamudi firmly believes that pharmacists are the key to achieve
preventive healthcare globally and for that it is essential to have a ‘a
pharmacist in every pharmacy’. High on his agenda are the fight against
antimicrobial resistance, medication safety and reduction of medication
errors, drug anticounterfeiting and quality pharmaceutical care to all. He
was one of the first Trustees when the CPA achieved charitable status in
2015.

Raymond Anderson

Immediate Past President

Raymond has experience of working in Community Pharmacy for over thirty-six years, which has enabled him to gain an understanding of the issues facing pharmacy both locally and nationally. His current post is as a partner at Andersons Pharmacy, Portadown. He is an Independent Pharmacy Prescriber since 2007 and has a history of working with GP’s, holding hypertension and hyperlipidaemia clinics and reviewing and supporting patients with long-term conditions.

Raymond has been appointed to many advisory committees and has been a Member of the Council of the Pharmaceutical Society of Northern Ireland, holding the post of Treasurer from 2002 to 2005 and President from 2006 to 2009. He has been a member of DHSS&PS Central Pharmaceutical Advisory Committee and is a past Chairman. He was a member of the Professional Development committee at the Pharmaceutical Society of Ireland 2012 to 2015.

With a strong interest in pharmacy issues in Europe and the Commonwealth, Raymond was President of the Commonwealth Pharmacists’ Association from 2007 to 2017, and the elected representative for the Pharmaceutical Group of the European Union (PGEU) for Northern Ireland and member of the Pharmaceutical Society of N.Ireland’s Pharmacy Forum. He was appointed to the European Medicines Agency’s “Pharmacovigilance Review Assessment Committee (PRAC)” by the European Commission in April 2016.

Raymond was appointed to the post of clinical lead Pharmacist to C&B Primary Care Partnership in 2012 and subsequently to C&B Integrated Care Partnership in 2013. He brings his breadth of experience to the ICP and was elected Chair in June 2014. He held this post until June 2016.

Raymond is a strong advocate for the role pharmacy can play in transforming the care of patients with long-term conditions (LTC’s). Medication is one of the key components in managing LTC’s and Pharmacists are in a key position to help reduce the pressure on our health services. He was one of the first Trustees when the CPA achieved charitable status in 2015.

Zaheer-Ud-Din Babar

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He has worked as an academic in Malaysia, New Zealand and in the United Kingdom and understands the health systems and pharmacy globally.  He is known for his work in pharmaceutical policy and practice, including quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics.

Previously he was the Head of Pharmacy Practice at the University of Auckland and received Vice Chancellor’s Research Excellence Award from the University. He has published in high impact journals such as PLoS Medicine and Lancet and has acted as a consultant for World Health Organization, Royal Pharmaceutical Society, Health Action International, International Union Against Tuberculosis and Lung Disease, World Bank, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand.

His other work includes “Economic evaluation of pharmacy services”, “Pharmaceutical prices in the 21st century”, “Pharmaceutical policies in countries with developing healthcare systems “, and “Pharmacy Practice Research Methods”. Published by Elsevier and Adis/Springer, the books are used in curriculum design, policy development and for referral all around the globe. Professor Babar is also the Editor-in-Chief of BMC Journal of Pharmaceutical Policy and Practice and can be contacted at z.babar@hud.ac.uk.

Claire Anderson

Claire is a Professor of Social Pharmacy, Division of Pharmacy Practice and Policy,  School of Pharmacy, University of  Nottingham, UK. She is currently leading a UKAID funded project on transforming pharmacy and chemistry education in Kenya.

Tom Kenny

Tom started his professional career in General Practice using improvement science to transform his own Practice. From there he moved into NHS management and then into Public Health Medicine. Tom has worked at every level of commissioning in the NHS as clinical director for practice based commissioning, director of commissioning for a primary care trust, medical adviser for specialised commissioning and medical adviser for national highly specialised commissioning. During this time Tom worked with NSCAG, NCG, and AGNSS in the programme evaluating drugs for use in rare diseases that became the NICE process for evaluating drugs for Ultra-Orphan diseases. Tom was director of external relations and then director of research delivery and impact for the NIHR Evaluation, Trials and Studies Co-ordinating Centre. During this time Tom oversaw the delivery of a portfolio of >800 active research projects across 5 of the NIHR programmes and led the work supporting NICE’s articulation of future research needs and worked with each guideline group to ensure that research recommendations where well constructed and articulated. Tom has worked with a number of pharmaceutical companies supporting the design of research, interpretations of finding and articulation of evidence to facilitate better payer decision-making. Tom now works for Spoonful of Sugar as CEO and Medical Director leading the core team, ensuring the highest quality of the design and delivery of their research programmes and overseeing the clinical content of all projects.

Oksana Pyzik

Teaching Fellow
Department of Practice and Policy, UCL School of Pharmacy, London

With a background in global health Oksana is heading up the UCL  ‘Fight the Fakes’ campaign to tackle ‘fake’ medicines. Oksana has also partnered with the United Nations for the Global Partnership for Youth in the Post- 2015 Development Agenda (GPY 2015) to lobby local and national government to prioritise youth in the development agenda.

As a Fellow at University College London (UCL) School of Pharmacy, Oksana is also leading the UCL Global Citizenship Programme on Infectious Diseases and will be sharing her expertise in education, policy and regulation to support many of our member organisations in their efforts to safeguard public health.